Position in EDSA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$742
+$541 QoQ
Shares Held
142
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EDSA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TD Waterhouse Canada Inc. holds $47,772,038 across 79 Biotechnology names. EDSA ranks #50 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABCL |
AbCellera Biologics Inc.
|
9,564,659 | $33,380,659 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,774 | $6,150,641 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,133 | $2,420,681 | |
| 4 | RPRX |
Royalty Pharma plc
|
36,933 | $1,771,676 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,971 | $652,144 | |
| 6 | CNTA |
Centessa Pharmaceuticals plc
|
15,595 | $619,433 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
2,032 | $603,443 | |
| 8 | EPRX |
Eupraxia Pharmaceuticals Inc.
|
81,725 | $591,689 |
All Filings in EDSA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $742 | 142 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $201 | 142 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $350 | 142 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $288 | 142 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $346 | 142 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $238 | 142 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $631 | 142 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $607 | 142 | Shares | Defined | 2024-11-12 | |
| 2024-03-31 | $594 | 142 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $648 | 142 | Shares | Defined | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||